Lallemand Health Solutions, a lab to shelf manufacturer of probiotic solutions, is proud to be a sponsor and to present at Pharmabiotics 2019. The event takes place March 13-14 at the New Cap Event Center in Paris (France) and focuses on the latest scientific advancements, regulatory information, and live bio therapeutics. We invite you to come by our booth to learn how working with a research-driven, vertically integrated manufacturer can provide the custom or ready-to-market formulation you need.
Don’t Miss Dr. Thomas Tompkins Presentation on March 13 at 15:40 p.m. in Room 1
Dr. Tompkins presentation “A Comprehensive Review of a Pharmabiotic Composition in the Management of Irritable Bowel Syndrome in a Chinese Population” is a systematic review and meta-analysis of clinical studies conducted in China between 2008 and 2018 using the products Medilac-S (adult) and Medilac-Vita (children) also known as IBacilluS+ (Enterococcus faecium R0026and Bacillus subtilis R0179)1. These products were used in different applications including the management of symptoms of Irritable Bowel Syndrome (IBS). In a systematic review of the literature, more than 100 clinical studies have been identified that described a positive outcome, in terms of clinical efficacy in patients with IBS using these formulations. Dr. Tompkins presentation will focus on the strength of the clinical evidence as well as make recommendations of the appropriate dose, duration of treatment, age group and the realistic expectations of improvement for the three different types and symptoms of IBS.
Mingle and Meet with Us
Our team of probiotic experts are keen to present our newest product ComboCap®’Biotic, the world’s first side-by-side, dual-chamber, wet-and-dry capsule with a moveable membrane that provides an unlimited range of probiotic formula possibilities. They are also eager to discuss potential partnership and licensing opportunities as well as share the latest research and innovation in the Brain-Gut Axis, Gut Health, Immunity, Women’s Health, Oral Health, and Sport probiotic categories.
We are looking forward to meeting you in Paris.
- Sohail G, Xu X, Christman MC, Tompkins TA. Probiotic Medilac-S® for the induction of clinical remission in a Chinese population with ulcerative colitis: A systematic review and meta-analysis. World J Clin Cases 2018 December 6; 6(15): 961-984 Open-access article: https://www.wjgnet.com/2307-8960/full/v6/i15/961.htm
About Lallemand Inc.
Lallemand Inc. is a privately owned Canadian company specializing in the development, production, and marketing of yeast and bacteria, and other ingredients linked to these microorganisms or their markets.
Lallemand Health Solutions. Quality Probiotics. Complete Solutions.
Founded in 1934, Lallemand Health Solutions is a vertically integrated probiotic manufacturer specializing in the research, development, and manufacturing of ready-to-market and custom probiotic formulations. Our products target specific populations and health segments that include gut health, natural defenses, women’s health, brain-gut axis, oral health, and sport. Products include a range of 500+ ready-to-market Expert’Biotics™ that use our proprietary Lacidofil®, ProbioKid®, Probio’Stick®, and IBacilluS+ formulas and customizable Smart’Biotics™ and Unique’Biotics™ which are created using our Harmonium, Lafti® or Rosell® strains and different ingredients. We have two research and development laboratories; an Applied Research facility located in Toulouse, France, and the Rosell® Institute for Microbiome and Probiotics in Montreal, Canada. Our dedicated probiotic production plants are certified to the highest quality standards: cGMP, Pharma GMP, Health Canada (NNHPD), USP Quality Systems GMP audited (Canada), ISO 9001 and ISO 22000 (France). Lallemand Health Solutions products are available in 60+ countries across five continents and is ready to service your probiotic needs.
Marketing Group Manager